Meteora Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-246,200
Closed -$748K 194
2024
Q4
$748K Buy
+246,200
New +$1.07M 0.25% 76

Other funds holding RVNC